Camber Pharmaceuticals recalls

Camber Pharmaceuticals has 5 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 17 May 2023. 4 are still ongoing. The most frequent reason is nitrosamine impurity.

Total recalls5since 2019

Last 12 months0reported

Class I120% of total

Ongoing4latest 17 May 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 1 20%Class II 3 60%Class III 1 20%

Why camber pharmaceuticals is recalled

Product types

Blood Pressure Medication360%
Seizure Medication120%

Brands

By year

2023120%
2022120%
2019360%

Ongoing camber pharmaceuticals recalls

4 active

Reported	Class	Recall	Company	Reason	Where
17 May 2023Drug	CLASS I	Atovaquone Oral Suspension USP, 750 mg recalledAtovaquone	Camber Pharmaceuticals	Other Bacterial Contamination	Nationwide
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 25 mg recalled by Camber PharmaceuticalsLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 100 mg recalledLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 50 mg recalled by Camber PharmaceuticalsLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide

All camber pharmaceuticals recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
17 May 2023Drug	CLASS I	Atovaquone Oral Suspension USP, 750 mg recalledAtovaquone	Camber Pharmaceuticals	Other Bacterial Contamination	Nationwide
21 Dec 2022Drug	CLASS III	Lacosamide Oral Solution, USP, CV, 10mg/mL recalledLacosamide	Camber Pharmaceuticals	Potency & Assay	Nationwide
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 25 mg recalled by Camber PharmaceuticalsLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 100 mg recalledLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets USP, 50 mg recalled by Camber PharmaceuticalsLosartan Potassium	Camber Pharmaceuticals	Nitrosamine Impurity	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.